51 – 60 of 166
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
The impact of immunomodulating treatment on the immunogenicity of COVID-19 vaccines in patients with immune-mediated inflammatory rheumatic diseases compared to healthy controls. A Swedish nationwide study (COVID19-REUMA)
- Contribution to journal › Article
-
Mark
Regulatory B-cells are reduced in the blood in patients with granulomatosis with polyangiitis, and fail to regulate T-cell IFN-γ production
- Contribution to journal › Article
-
Mark
Long-term outcomes and prognostic factors for survival of patients with ANCA-associated vasculitis
- Contribution to journal › Article
-
Mark
Predictors of hypogammaglobulinemia in ANCA-associated vasculitis after a rituximab-based induction : a multicentre study
- Contribution to journal › Article
- 2022
-
Mark
Evaluation of revised classification criteria for giant cell arteritis and its clinical phenotypes
- Contribution to journal › Article
-
Mark
Severe infections in patients with ANCA-associated vasculitis treated with rituximab
- Contribution to journal › Article
-
Mark
Clustering of anti-neutrophil cytoplasmic antibody-associated vasculitis - using a pre-processed harmonised dataset
(2022) 20th International Vasculitis and ANCA workshop
- Contribution to conference › Abstract
-
Mark
An update on the epidemiology of Behçet’s disease in southern Sweden
(2022) 20th International Vasculitis and ANCA workshop
- Contribution to conference › Abstract
-
Mark
Myocardial infarction in ANCA-associated vasculitis- a population-based cohort-study
(2022) 20th International Vasculitis and ANCA workshop
- Contribution to conference › Abstract
-
Mark
Epidemiology and Clinical Characteristics of Adult-Onset IgA Vasculitis in Southern Sweden
(2022) 20th International Vasculitis and ANCA workshop
- Contribution to conference › Abstract
